This result may also be attributed to tumor histological differences, where ductal carcinoma in situ is more common in BRCA2. NCC guidelines recommend that surveillance of breast cancer should be conducted with both mammography and MRI in BRCA patients. The gene discussed is BRCA2; the disease is breast carcinoma.